Harold Selick

Harold E.
Selick is the founder of Epiphany Biosciences, Inc., founded in 2001.
Dr. Selick was the founder of Camitro UK Ltd., founded in 1999, and served as Chairman from 1999 to 2014.
Dr. Selick is also the founder of ArQule UK Ltd...
Dr. Selick is Chief Executive Officer & Director at Hinge Bio, Inc. since 2023.
Dr. Selick is Chairman at Protagonist Therapeutics, Inc. since 2014.
Dr. Selick is Independent Director at Protagonist Pty Ltd. Dr. Selick is Director at Molecular Templates OpCo, Inc. Dr. Selick is Venture Partner at Mission Bay Capital Management, Inc. Former positions include Chairman & Chief Executive Officer at Threshold Pharmaceuticals, Inc. from 2002 to 2017; President & Chief Executive Officer at Camitro Corp.
from 1999 to 2002; Chairman at DiObex, Inc.; Chairman at Catalyst Bioscience, Inc. from 2003 to 2015 and from 2015 to 2018; Chairman at PDL BioPharma, Inc. from 2009 to 2019; Chairman at Molecular Templates, Inc. from 2017 to 2024; Director at Amunix Pharmaceuticals, Inc.; Director at Amunix, Inc.; Staff Scientist at Protein Design Labs, Inc. from 1983 to 1985; Principal at Anergen, Inc.; Vice President-Research at Glaxo Wellcome Plc; Partner at Sofinnova Investments, Inc. from 2002 to 2007; Vice President-Research at Affymax Research Institute from 1992 to 2002; Vice Chancellor-Business Development & Innovation at The University of California, San Francisco from 2017 to 2022.
Education includes undergraduate and doctorate degrees from the University of Pennsylvania.